11-45909930-C-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS1

The NM_004813.4(PEX16):​c.*324G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 682,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

PEX16
NM_004813.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.38

Publications

0 publications found
Variant links:
Genes affected
PEX16 (HGNC:8857): (peroxisomal biogenesis factor 16) The protein encoded by this gene is an integral peroxisomal membrane protein. An inactivating nonsense mutation localized to this gene was observed in a patient with Zellweger syndrome of the complementation group CGD/CG9. Expression of this gene product morphologically and biochemically restores the formation of new peroxisomes, suggesting a role in peroxisome organization and biogenesis. Alternative splicing has been observed for this gene and two variants have been described. [provided by RefSeq, Jul 2008]
PEX16 Gene-Disease associations (from GenCC):
  • peroxisome biogenesis disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • peroxisome biogenesis disorder 8A (Zellweger)
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
  • peroxisome biogenesis disorder 8B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • Zellweger spectrum disorders
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000125 (19/152342) while in subpopulation AMR AF = 0.00098 (15/15308). AF 95% confidence interval is 0.000603. There are 0 homozygotes in GnomAd4. There are 8 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEX16NM_004813.4 linkc.*324G>C 3_prime_UTR_variant Exon 11 of 11 ENST00000378750.10 NP_004804.2 Q9Y5Y5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEX16ENST00000378750.10 linkc.*324G>C 3_prime_UTR_variant Exon 11 of 11 1 NM_004813.4 ENSP00000368024.5 Q9Y5Y5-1
PEX16ENST00000241041.7 linkc.*159G>C 3_prime_UTR_variant Exon 11 of 11 1 ENSP00000241041.3 Q9Y5Y5-2
PEX16ENST00000523721.2 linkn.*240G>C downstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
152224
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000850
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000128
AC:
68
AN:
530566
Hom.:
0
Cov.:
6
AF XY:
0.0000815
AC XY:
23
AN XY:
282100
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
15356
American (AMR)
AF:
0.00205
AC:
64
AN:
31280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31992
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54996
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32118
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2246
European-Non Finnish (NFE)
AF:
0.00000947
AC:
3
AN:
316626
Other (OTH)
AF:
0.0000341
AC:
1
AN:
29300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
152342
Hom.:
0
Cov.:
34
AF XY:
0.000107
AC XY:
8
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41584
American (AMR)
AF:
0.000980
AC:
15
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.537
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000227

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.027
DANN
Benign
0.46
PhyloP100
-2.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs879320611; hg19: chr11-45931481; API